Deadline for applications: midnight NZST 04 October 2020
Download Award Information
The Boehringer Ingelheim New Zealand Primary Care Grant aims to support research which will address the issue of access to primary care in New Zealand, particularly during restrictions like those faced during the COVID-19 pandemic.
Primary care can include general practice, allied health services, community health and community pharmacy.
The grant is valued at NZD 5000 and will support studies for one year only.
This grant is open to all members of the Society from all professional groups.
To be eligible for the award, the applicant must:
Propose research which will take place in New Zealand.
 Financial member of the TSANZ who has obtained the support of a proposer and seconder and has been endorsed by the TSANZ Board
The following conditions must be met by members receiving this award:
Note: These conditions must be met to remain eligible for further award rounds.
Applicants must submit only an electronic application as a single PDF file via the online abstract submission portal.
In order to be considered for this award, your application must be submitted by the deadline and must include:
Applications will be assessed by the Research Subcommittee according to the following criteria (based on NHMRC criteria):
Significance and Innovation
Track Record relative to opportunity
In the event of there being no suitable applicants the grant may not be awarded.
The award will be acknowledged publically and presented at a future suitable event.